![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Versarien Plc | LSE:VRS | London | Ordinary Share | GB00B8YZTJ80 | ORD 0.01P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.0015 | 2.22% | 0.069 | 0.065 | 0.069 | 0.069 | 0.065 | 0.07 | 10,810,277 | 09:04:39 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Chemicals & Chem Preps, Nec | 5.45M | -13.53M | -0.0091 | -0.08 | 1M |
Date | Subject | Author | Discuss |
---|---|---|---|
19/12/2019 08:33 | Welcome to the teepee club , scrutable;) we can be misunderstood together, if you ever replied;) | ![]() 1teepee | |
19/12/2019 08:29 | Now you had it, you cannot go round attacking old guys and have the shiny tops come for your hide;) | ![]() 1teepee | |
19/12/2019 08:27 | I did start my own thread and you are welcome to use it. As I use yours;) | ![]() 1teepee | |
19/12/2019 08:22 | The recent suggestion of cash problems resulted in considered responses by posters and the directors based on fact and logic. Those responses were the more effective for that and for me extremely helpful. In contrast the name calling does not help and is a distraction on a board which generally provides valuable insights | ![]() garfield31 | |
19/12/2019 08:19 | I see the much criticised, heavily shorted, pioneering and disruptive Tesla’s share price closed at a record high last night - just an observation! AIMHO DYOR etc. | lovat scout | |
19/12/2019 08:17 | Good on ya superg, dictatorships work! | ![]() zagrosfold | |
19/12/2019 08:15 | thanks jointer. I love the way that h-BN is compared to "traditional graphene"! Graphene already regarded as traditional ;-) ".... Summary The field of nano-fabrication and functionalization is moving at a very rapid pace. The expected capability of a 2D type h-BN structure enables the researchers to generate new nanoscale materials. These advances have been brought together by the combination of different organic and inorganic building blocks on this 2D platform. In part, the explorations by expert material researchers have already confirmed the notable manipulation strategies of h-BN for various biomedical purposes. The new class h-BN (white graphene) holds an even more attractive platform than most studying graphene oxide (GO) to deliver the anticancer medications. In this way, the anticancer drug like doxorubicin or therapeutic gene can release at the target site. Thus, it is likely that anticancer drug-loaded h-BN will enter advances cancer therapy soon." | ![]() grabster | |
19/12/2019 08:05 | vrs has quality hbn...it was part of the significant tender win. perhaps further down the line. Hexagonal Boron Nitrides (White Graphene): A Promising Method for Cancer Drug Delivery "Anticancer Drug Delivery The nanocarrier encapsulated anticancer drug has the potential to maximized therapeutic effect and minimized unwanted side effects. However, it is still challenging to design such capable nanocarriers that are simultaneously biocompatible, soluble, and stable in physiologic environments, and could deliver required anticancer drugs. In this case, 2D h-BN like nanomaterials has great potential as anticancer nano-carriers (Table 1). " | jointer13 | |
19/12/2019 07:47 | it must be costing a fortune lucky with all the signal failures. we have the solution. | jointer13 | |
19/12/2019 07:40 | Is there light at the end of the tunnel with all of the signal failures and the aecom arch being the solution ? All it needs is for funding to be given a green light and it will get very busy problem solving. | ![]() luckyorange | |
19/12/2019 06:50 | Bobs worth 👍 Podcast today | markyboy5 | |
19/12/2019 01:00 | Good evening all I'm sure we are all aware that the tfl finance meeting was on yesterday and the plan was on the agenda for approval.The following document was produced on 14 Nov 2019 and contains a response by the mayor of London in relation to signals disruptions since May 2016 by month across all lines.His comments indicate a significant commitment which is also backed up in there 2019/20 to 2023/24 (see page 24)https://www.londo | ![]() mavfav | |
18/12/2019 23:42 | Watching Cullion / Dean Haigh (never been a shareholder) telling others what to do is hilarious.Night all, better luck tomorrow. | ![]() festario | |
18/12/2019 22:57 | Why does he rattle on about the election! ? HS2 ? Don't get it. | ![]() alchemy | |
18/12/2019 22:45 | Markboy5 - fingers crossed AECOM ARCH will turn green soon! Email recently received from Neil when I asked if testing was now complete. My understanding is the testing was scheduled for 6 months from June (Bristol event with AECOM), arch has performed as expected. Until there is am RNS with confirmation it is speculation. Hopefully with the election out of the way we are good to go. Neill Ricketts Chief Executive t: +44 (0) 1242 269 122 m:+44 (0) 7912 869066 e: neill.ricketts@versa | ![]() bobsworth | |
18/12/2019 22:02 | Great news today about VRS PLC Airbus Graphene Flagship Project and VRS’s participation being funded by the European Commission. This project led by Airbus is all part of their amazing Graphene Flagship which is the European Union’s biggest scientific research initiative. With a budget of €1 billion, it represents a new form of joint, coordinated research initiative on an unprecedented scale. Looking at their Graphene Technology and Innovation Road Map it just reminds us of all the graphene initiatives areas that VRS might and are currently playing a part in. It’s just mind blowing! The timeframes also remind us that VRS was never going to be a short time investment but thanks to their shear hard work and unique high-quality graphene they are quickly getting there. Happy to be invested & looking forward to a very newsy 2020. | ![]() bobsworth |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions